Jing Fan
Chief Medical OfficerDr. Jing Fan is Chief Medical Officer of TransThera Sciences (Nanjing), Inc. (formerly known as Nanjing TransThera Biosciences Co. Ltd.) from November 1, 2022. Dr. Fan joined our Group on November 1, 2022. She is primarily responsible for clinical and regulatory affairs. Prior to joining our Group, Dr. Fan served as a lead clinical scientist of GlaxoSmithKline from September 1999 to September 2005, an international clinical company and she was responsible for multiple clinical phase I-IV including small molecule target compounds. She also served as an associated director of Bristol-Myers Squibb Company from October 2005 to December 2007, a global biotechnology company and was responsible for clinical development for registration phase III studies and Phase I study. Dr. Fan also served as a director of Array Biopharma from March 2008 to September 2008, a global biotechnology company and was responsible for developing strategy and clinical development plan. She also served as a director of Elsai Co., Ltd. from October 2008 to June 2013, a global biotechnology company and was responsible for phase I-III studies. Dr. Fan also served as a senior global clinical program leader of Boehringer-Ingelheim from July 2013 to October 2017, a global science-led biopharmaceutical company and was responsible for global clinical development. She also served as a global clinical lead of AstraZeneca from November 2017 to August 2019, a global biopharmaceutical company and was responsible for developing and executing strategy and clinical development plan for Immuno-Oncology products products. Dr. Fan also served as a vice president of Blueprint Medicine, a global biotechnology company and was responsible for clinical development. In addition, she also served as a chief clinical officer of NeoImmuneTech, Inc, a global biopharmaceutical company and was responsible for clinical development, clinical operations, pharmacovigilance and biostats. Dr. Fan obtained the bachelor?s degree of clinical medicine from Jiangxi Medical College (now known as Nanchang University Jiangxi Medical College in the PRC in July 1985 and further obtained the master?s degree of biophysics and physiology from Sun Yat-sen University of Medical Sciences (now known as Sun Yat-sen University in the PRC in July 1991. Dr. Fan completed her postdoctoral training at Georgetown University, School of Medicine in the United States in September 1997.
Positions
- Company NameTransThera Sciences (Nanjing), Inc.Stock Code02617PositionChief Medical OfficerColleagues
- YWYongqian WuFounder, CEO & Chairman
- DWDi WuPresident, Financial Controller & Executive Director
- DSDelong SunChief Operating Officer
- SCSongxi CuiVice President of Operations
- SPShu Pai LiIndependent Non-Executive Director
- HYHoi Yam ChuiIndependent Non-Executive Director
- WZWeili ZhaoEmployees Representative Chairwoman of Supervisory Board
